humana8-k09172013.htm
 
 
 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, DC  20549
 
FORM 8-K
 
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
 
 
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of report (Date of earliest event reported):
    September 16, 2013
 
Humana Inc.
 
(Exact Name of Registrant as Specified in Its Charter)
 
 
Delaware
 
(State or Other Jurisdiction of Incorporation)
 

1-5975
61-0647538
(Commission File Number)
(IRS Employer Identification No.)
 

 
500 West Main Street, Louisville, KY
40202
(Address of Principal Executive Offices)
(Zip Code)

502-580-1000
 
(Registrant's Telephone Number, Including Area Code)
 
(Former Name or Former Address, if Changed Since Last Report)
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 

 
 
       o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 

 

Item 8.01   Other Events.

In its quarterly report on Form 10-Q for the quarter ended June 30, 2013, Humana Inc. (the “Company”) disclosed that all material contracts between Humana and The Centers for Medicare and Medicaid Services (“CMS”) relating to the company’s Medicare business had been renewed for 2014.  The Company is now reporting that all of its 2014 Medicare Advantage (“MA”) and Prescription Drug Plan (“PDP”) offerings filed with CMS in June 2013 have been approved by CMS and the related contracts have been executed (referred to as the “CMS Contracts”).
 
Humana will offer the following plans for its Medicare members effective beginning January 1, 2014:
The marketing process for the Company’s 2014 Medicare offerings begins on October 1, 2013, with enrollment beginning October 15, 2013.
 
Each of the CMS Contracts was effective when signed, has a termination date of December 31, 2014 and may be renewed for successive one-year terms subject to the consent of the parties and their agreement on a bid as submitted by Humana or its subsidiaries. Each of the CMS Contracts may be terminated by either party in the event of the failure by the other to substantially carry out its obligations under the CMS Contracts, and by CMS in the event of a violation by Humana of relevant CMS regulations.
 


 
 

 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
HUMANA INC.
 
 
 
BY:     /s/   Steven E. McCulley                              
              Steven E. McCulley
              Vice President and Controller
              (Principal Accounting Officer)
 
 
Dated:           September 16, 2013